Pre-earnings brief
Reports
Fri, Oct 30, 2026
Est. EPS
—
Est. revenue
—
Implied move
±10.6%
EPS beat rate
63%
BrightSpring Health Services, Inc. operates in the health care sector, providing essential services that support individuals with complex health needs. With a market cap of $13 billion, the company plays a crucial role in the growing demand for health care services, especially as the population ages and requires more specialized care.
Last quarter
In Q2 2026, BrightSpring reported an EPS of $0.45, exceeding expectations by 21.62%. However, the stock fell 18.07% the following day, indicating market concerns despite the earnings beat.
Management promises and guidance
EPS beat streak
2Q
EPS beat rate
63%
Avg EPS surprise
+20.49%
Avg 1-day reaction
+1.99%
Overall expectations are mixed as the company has shown strong earnings surprises in recent quarters, but market reactions have been volatile. Investors are looking for consistent revenue growth and management's outlook on future performance.
Bull case
If BrightSpring continues to exceed EPS estimates and shows strong revenue growth, it could regain investor confidence and see a positive stock reaction.
Bear case
Conversely, if the company fails to meet expectations or provides cautious guidance, it may face significant downward pressure on its stock price.
The print will turn on these.
Q1
What is the expected EPS for Q3-2026?
The EPS figure will be crucial in determining whether the company can maintain its recent trend of beating estimates and restoring investor confidence.
Q2
How has patient volume changed compared to the previous quarter?
Changes in patient volume will provide insights into the demand for services and the company's ability to grow its revenue.
—
Est. EPS
$6.73
Est. Rev
$4.6B
Impl. Move
±2.6%
Why consensus could be wrong
The Street may be underestimating the potential for BrightSpring to achieve higher patient volumes and revenue growth, given its recent operational improvements.
Supporting evidence
The company has consistently beaten EPS estimates, suggesting stronger underlying performance than anticipated.
Options pricing indicates a significant move, reflecting uncertainty that may not align with the company's growth trajectory.
Key risk
If patient volume exceeds expectations, it could lead to a significant upward revision in revenue forecasts.
Pre-commit to what would confirm each case.
The core thesis revolves around the company's ability to sustain growth and profitability in a competitive health care environment.
Bull confirmed if
An EPS of $0.50 or higher would confirm strong operational performance and growth potential.
Bear confirmed if
An EPS below $0.40 would indicate potential challenges in maintaining profitability.
What the market is pricing for the move.
Implied Move
±10.56%
Historical Avg
±9.3%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.
Options are pricing ±10.6% while BTSG has averaged ±9.3% over the last 8 prints — setup is roughly in line with history.
ATM IV
0.5%
30d HV
37.9%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 11 of 30 (37%)
This setup has occurred 30 times across Health Care in the last 2 years. 19 of 30 (63%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 3.7%, with a raw directional average of -0.1% (roughly flat historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
108.09%
of float
Insider
3.13%
of float
Holders
592
institutions
Top Holders· as of Jun 2026
Kohlberg Kravis Roberts & Co. L.P.
26,829,880 sh · $1.7B
13.56%
-35.8%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If BrightSpring beats expectations, history suggests a potential stock increase of around 9.61%, confirming a positive outlook.
In line / cautious
If results are in line with expectations but management provides cautious commentary, the stock may react neutrally or slightly down.
Miss
If the company misses expectations, history suggests a potential decline of around 9.23%, indicating market disappointment.
The lines on the call that would change the story.
Blackrock Inc.
24,027,537 sh · $1.5B
12.14%
22.6%
FMR, LLC
13,393,155 sh · $854.5M
6.77%
-36.2%
Invesco Ltd.
11,942,017 sh · $761.9M
6.04%
4.0%
Vanguard Portfolio Management LLC
9,946,458 sh · $634.6M
5.03%
23.8%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.